ATRA treatment down-regulated the expression of RANKL a key osteoclastogenic molecule expressed in CD4+ T-cells and fibroblast-like synoviocytes and osteoclast formation in arthritis joints was reduced (73). This evidence concerns the gene CD4 and arthritic joint disease.